synvoma offers an intelligent detection platform for cardiac toxicity screening, positioning the company within the pre-clinical research segment of the pharmaceutical industry. It sells into North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa, though further company details are not disclosed in available records.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét